-
公开(公告)号:EP3886830A1
公开(公告)日:2021-10-06
申请号:EP19818285.9
申请日:2019-11-28
IPC分类号: A61K31/165 , A61P3/10 , A61P3/06 , A61P35/00
-
公开(公告)号:EP3142642B1
公开(公告)日:2018-08-29
申请号:EP15722359.5
申请日:2015-04-08
IPC分类号: A61K9/127 , A61K31/351 , A61K47/40 , A61K47/69
CPC分类号: A61K9/1271 , A61K31/351 , A61K47/40 , A61K47/6951 , Y02A50/411
摘要: Provided are liposomes encapsulating mupirocin, with particular benefit for systemic therapeutically effective delivery. Also provided herein are pharmaceutical compositions including the liposomes and methods of using them. The liposomes include a lipid membrane and an intraliposomal compartment, the intraliposomal compartment encapsulating mupirocin, at least one cyclodextrin compound and a pH dependent ionizable anion, e.g. acetate.
-
公开(公告)号:EP4125809A1
公开(公告)日:2023-02-08
申请号:EP21718237.7
申请日:2021-03-25
IPC分类号: A61K9/00 , A61K9/127 , A61K31/41 , A61K31/4178 , A61K31/4184 , A61K31/4245 , A61K47/12 , A61K47/40
-
公开(公告)号:EP4010316A1
公开(公告)日:2022-06-15
申请号:EP20758352.7
申请日:2020-08-06
IPC分类号: C07D209/20 , C07D239/22 , C07D277/28 , C07D277/42 , C07D405/12 , A61P3/00 , A61K31/404 , A61K31/505
-
公开(公告)号:EP4319734A2
公开(公告)日:2024-02-14
申请号:EP22722358.3
申请日:2022-04-06
申请人: Hadasit Medical Research Services&Development Ltd. , Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
IPC分类号: A61K31/18 , A61K31/4192 , A61K31/428 , A61P3/10
-
公开(公告)号:EP3142642A1
公开(公告)日:2017-03-22
申请号:EP15722359.5
申请日:2015-04-08
IPC分类号: A61K9/127 , A61K31/351 , A61K47/40 , A61K47/69
CPC分类号: A61K9/1271 , A61K31/351 , A61K47/40 , A61K47/6951 , Y02A50/411
摘要: Provided are liposomes encapsulating mupirocin, with particular benefit for systemic therapeutically effective delivery. Also provided herein are pharmaceutical compositions including the liposomes and methods of using them. The liposomes include a lipid membrane and an intraliposomal compartment, the intraliposomal compartment encapsulating mupirocin, at least one cyclodextrin compound and a pH dependent ionizable anion, e.g. acetate.
摘要翻译: 提供包封莫匹罗星的脂质体,特别有益于全身治疗有效递送。 本文还提供包含脂质体的药物组合物及其使用方法。 脂质体包括脂质膜和脂质体内隔室,包封莫匹罗星的脂质体内区域,至少一种环糊精化合物和pH依赖性可电离阴离子,例如, 醋酸。
-
-
-
-
-